BiovaxID FDA Approval Status
FDA Approved: No
Brand name: BiovaxID
Company: Biovest International, Inc.
Treatment for: Non-Hodgkin's Lymphoma
BiovaxID is a personalized biologic therapeutic cancer vaccine for the treatment of non-Hodgkin’s lymphoma.
Development timeline for BiovaxID
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.